Atara Biotherapeutics (ATRA) Change in Acquisitions & Divestments (2014 - 2025)

Atara Biotherapeutics (ATRA) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $7.9 million in Q4 2025.

• Quarterly Change in Acquisitions & Divestments rose 127.5% year-over-year to $7.9 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $7.9 million (down 74.47% YoY) and the FY2025 annual result came in at $25.1 million, down 12.09% from the prior year.
• Change in Acquisitions & Divestments advanced to $7.9 million in Q4 2025, from $1000.0 in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $109.8 million in Q1 2021 to a low of $1000.0 in Q3 2025.
• A 5-year average of $46.8 million and a median of $54.5 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments soared 129.27% — and 2025, when it sank 99.97%.
• Tracing ATRA's Change in Acquisitions & Divestments over 5 years: stood at $54.5 million in 2021, then declined by 7.04% to $50.7 million in 2022, then tumbled by 80.29% to $10.0 million in 2023, then sank by 65.3% to $3.5 million in 2024, then surged by 127.5% to $7.9 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $7.9 million (Q4 2025), $1000.0 (Q3 2025), and $17.2 million (Q1 2025), per Business Quant data.